AiM  Vol.7 No.6 , June 2017
Eradication of Staphylococcus aureus and MRSA in the Nares: A Historical Perspective of the Ecological Niche, with Suggestions for Future Therapy Considerations
Abstract: Nasal colonization with pathogenic bacteria continues to present challenges for patients undergoing surgical procedures, and for the physicians that treat them. Even as molecular medicine produces ever faster and improved data sets for clinicians, it would benefit all medical personnel attempting to decolonize the nose to better understand the historical nasal decolonization data with specific reference to the ecological niche for these bacteria, as it has been recorded for more than a century. Much of the historical data points to the largest ecological niche for nasal Staphylococcus aureus as the vibrissae of the vestibulum nasi. A careful study shows that any topical antimicrobial preparation needs to successfully penetrate the deepest recesses of these specialized nasal hair follicles, if decolonization is to be adequately accomplished. This review highlights the most relevant data of the last 140 years concerning the staphylococcal ecological niche of the vibrissae. Also to be discussed will be a historical review of topical Mupirocin. Almost thirty years after its FDA approval, Mupirocin is still the most widely used topical antibiotic for decolonization therapy around the world. Correspondingly, new experimental in vitro data will be presented showing the differing efficacy of Mupirocin against multiple strains of HA-MRSA and CA- MRSA, based solely on the commercial topical formulation (non Mupirocin ingredients) that acts synergistically with the Mupirocin. Finally, the review will discuss why an understanding of these historical data is a vital component to integrate into any new or augmented nasal decolonization therapy.
Cite this paper: Bornstein, E. (2017) Eradication of Staphylococcus aureus and MRSA in the Nares: A Historical Perspective of the Ecological Niche, with Suggestions for Future Therapy Considerations. Advances in Microbiology, 7, 420-449. doi: 10.4236/aim.2017.76034.

[1]   Marchesi, J.R. (2014) The Human Microbiota and Microbiome. CABI.

[2]   Maloy, S. and Moselio, S. (2006) The Era of Microbiology: A Golden Phoenix. International Microbiology, 9, 1.

[3]   Shuter, J., Hatcher, V.B. and Lowy, F.D. (1996) Staphylococcus aureus Binding to Human Nasal Mucin. Infection and Immunity, 64, 310-318.

[4]   Aly, R., Shinefield, H.I., Strauss, W.G. and Maibach, H.I. (1977) Bacterial Adherence to Nasal Mucosal Cells. Infection and Immunity, 17, 546-549.

[5]   Aly, R., Shinefield, H.R., Litz, C. and Maibach, H.I. (1980) Role of Teichoic Acid in the Binding of Staphylococcus aureus to Nasal Epithelial Cells. The Journal of Infectious Diseases, 141, 463-465.

[6]   Peterson, A. (2006) Townsend. Ecologic Niche Modeling and Spatial Patterns of Disease Transmission.

[7]   Watson, W.S. (1875) Diseases of the Nose and Its Accessory Cavities. Lewis.

[8]   Ogston, A. (1882) Micrococcus Poisoning. Journal of Anatomy and Physiology, 17, 24-58.

[9]   Rosenbach, A.J. (1884) Mikro-Qrganismenbei den Wund-Infections-Krankheiten des Menschen. J.F. Bergmann, Wiesbaden, 18.

[10]   Baber, E.C. (1886) A Guide to the Examination of the Nose: With Remarks on the Diagnosis of Diseases of the Nasal Cavities. Chapter 1, Lewis.

[11]   Cunningham, D.J. (1902) Cunningham’s Textbook of Anatomy. W. Wood.

[12]   Lack, H.L. (1906) The Diseases of the Nose and Its Accessory Sinuses. Longmans, Green.

[13]   Braun-Falco, O., Plewig, G. and Wolff, H.H. (2013) Dermatology. Springer-Verlag, Berlin.

[14]   Park, W.H. and Wright, J. (1889). Nasal Bacteria in Health. The Journal of Laryngology, Rhinology, and Otology, 13, 124-130.

[15]   Park, R. (1891) Pyogenic Organisms. Third Mütter Lecture, Series of 1890-91. Annals of Surgery, 13, 378.

[16]   Galloway, J., et al. (1901) A Discussion on the Role of Cocci in the Pathology of the Skin. The British Medical Journal, 794-797.

[17]   Ghosh, S. (2015) Neonatal Pustular Dermatosis: An Overview. Indian Journal of Dermatology, 60, 211.

[18]   Schimmelbusch, C. (1895) A Guide to the Aseptic Treatment of Wounds. GP Putnam’s Sons.

[19]   Thomson, C. and Hewlett, R.T. (1895) Micro-Organisms in the Healthy Nose. Medico-Chirurgical Transactions, 78, 239.

[20]   Shurly, E.L. (1905) A Treatise on Diseases of the Nose and Throat. Appleton.

[21]   Allen, R.W. (1913) The Bacterial Diseases of Respiration, and Vaccines in Their Treatment. HK Lewis.

[22]   Phillips, W.C. (1922) Diseases of the Ear, Nose and Throat: Medical and Surgical. Davis.

[23]   Herzig, A.J. (1926) A Further Study and Clinical Report of the Use of Acriviolet in Diseases of the Upper Respiratory Tract and Ear. The Laryngoscope, 36, 445-452.

[24]   Fleming, A. (1929) On the Antibacterial Action of Cultures of a Penicillium, with Special Reference to Their Use in the Isolation of B. Influenzae. British Journal of Experimental Pathology, 10, 226.

[25]   Keilty, R.A. (1930) The Bacterial Flora of the Normal Conjunctiva with Comparative Nasal Culture Study. American Journal of Ophthalmology, 13, 876-879.

[26]   Danbolt, N. (1932) Undersøkelser over staphylokokker:
Med saerlighenblikkpåfurunkilosensepidemiologi. Dybwad.

[27]   Davis, J.S. (1934) The Importance of Adequate Masking during Operation. Annals of Surgery, 100, 1008.

[28]   Connor, J.I. (1935) Staphylococcal Infections of the Skin and Their Treatment. British Medical Journal, 2, 1195.

[29]   Gillespie, E.H., Devenish, E.A. and Cowan, S.T. (1939) Pathogenic Staphylococci Their Incidence in the Nose and on the Skin. The Lancet, 234, 870-873.

[30]   Devenish, E.A. and Miles, A.A. (1939) Control of Staphylococcus aureus in an Operating-Theatre. The Lancet, 233, 1088-1094.

[31]   Veach, H.O. (1940) Aluminum Chloride in Folliculitis of the Nose. California and Western Medicine, 52, 76.

[32]   Sprawls, J.B. and Poe, C.F. (1943) A Study of the Germicidal and Bacteriostatic Properties of Some Commonly Used Antiseptics in Combination with Astringent Substances. Journal of the American Pharmaceutical Association, 32, 33-40.

[33]   Delafield, M.E., Straker, E. and Topley, W.W.C. (1941) Antiseptic Snuffs. British Medical Journal, 1, 145.

[34]   Thomas, A.M. (1941) Treatment of Diphtheria Carriers with Sulphathiazole Snuff. British Medical Journal, 2, 687.

[35]   Miles, A.A., Williams, R.E.O. and Clayton-Cooper, B. (1944) The Carriage of Staphylococcus (Ptogenes) aureus in Man and Its Relation to Wound Infection. The Journal of Pathology and Bacteriology, 56, 513-524.

[36]   Taylor, P.H. and Hughes, K.E.A. (1944) Infective Dermatoses Treated with Penicillin. The Lancet, 244, 780-784.

[37]   Gissane, W., Miles, A.A. and Williams, R.E.O. (1944) Design of Dressing Stations and Control of Wound Infection. British Journal of Industrial Medicine, 1, 90.

[38]   Lovell, D.L. (1945) Skin Bacteria—Their Location with Reference to Skin Sterilization. Surgery Gynecology & Obstetrics, 80, 174-177.

[39]   Lovell, D.L. (1945) Skin Bacteria: Their Role in Contamination and Infection of Wounds. Archives of Surgery, 51, 78-80.

[40]   Harkins, H.N. (1945) Cutis Grafts: Clinical and Experimental Studies on Their Use as a Reinforcing Patch in the Repair of Large Ventral and Incisional Herniae. Annals of Surgery, 122, 996.

[41]   Hobbs, B.C., Carruthers, H.L. and Gough, J. (1947) Sycosisbarbae: Serological Types of Staphylococcus Pyogenes in Nose and Skin and Results of Penicillin Treatment. The Lancet, 250, 572-574.

[42]   Moss, B., et al. (1948) Nose and Skin Carriage of Staphylococcus aureus in Patients Receiving Penicillin. The Lancet, 251, 320-325.

[43]   Evans, C.A., Smith, W.M., Johnston, E.A. and Giblett, E.R. (1950) Bacterial Flora of the Normal Human Skin. Journal of Investigative Dermatology, 15, 305.

[44]   Anning, S.T. (1953) Recurrent Boils. British Medical Journal, 1, 721.

[45]   Gould, J.C. (1955) The Effect of Local Antibiotic on Nasal Carriage of Staphylococcus pyogenes. Journal of Hygiene, 53, 379-385.

[46]   Williams, R.E.O., et al. (1959) Nasal Staphylococci and Sepsis in Hospital Patients. British Medical Journal, 2, 658.

[47]   Varga, D.T. and Arthur, W. (1961) Suppression of Nasal, Skin, and Aerial Staphylococci by Nasal Application of Methicillin. Journal of Clinical Investigation, 40, 2209.

[48]   White, A. and Jeremy, S. (1963) Nasal Reservoir as the Source of Extranasal Staphylococci. Antimicrobial Agents and Chemotherapy.

[49]   Montes, L.F. and Wilborn, WH. (1969) Location of Bacterial Skin Flora. British Journal of Dermatology, 81, 23-26.

[50]   Selwyn, S. and Harold, E. (1972) Skin Bacteria and Skin Disinfection Reconsidered. BMJ, 1, 136-140.

[51]   Baader, A. and Garre, C. (1887) Uber Antagonistenunter den Bacterien. Corresp. Bl. Schweiz. Ärzte, 13, 385-39.

[52]   Vuillemin, P. (1889) Antibioseetsymbiose. CR Association Francaise pour L’Avancement des Sciences, 2, 525-543.

[53]   Fuller, A.T., et al. (1971) Pseudomonic Acid: An Antibiotic Produced by Pseudomonas Fluorescens. Nature, 234, 416-417.

[54]   Sutherland, R., Comber, K.R., Mizen, L.W., Slocombe, B. and Clayton, J.P. (1976) Pseudomonic Acid, an Antibiotic Produced by Pseudomonas Fluorescens. Proceedings of the 16th Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago.

[55]   Hughes, J. and Graham, M. (1978) On the Mode of Action of Pseudomonic Acid: Inhibition of Protein Synthesis in Staphylococcus aureus. The Journal of Antibiotics, 31, 330-335.

[56]   Wuite, J., et al. (1983) Pseudomonic Acid: A New Topical Antimicrobial Agent. The Lancet, 322, 394.

[57]   Dacre, J.E., Emmerson, A.M. and Jenner, E.A. (1983) Nasal Carriage of Gentamicin and Methicillin Resistant Staphylococcus aureus Treated with Topical Pseudomonic Acid. The Lancet, 322, 1036.

[58]   Casewell, M.W. and Hill, R.L.R. (1983) Pseudomonic Acid and Control of Methicillin-Resistant Staphylococci. The Lancet, 322, 1312.

[59]   Chirife, J., et al. (1983) In Vitro Antibacterial Activity of Concentrated Polyethylene Glycol 400 Solutions. Antimicrobial Agents and Chemotherapy, 24, 409-412.

[60]   Vaamonde, G., et al. (1982) An Examination of the Minimal Water Activity for Staphylococcus aureus ATCC 6538 P Growth in Laboratory Media Adjusted with Less Conventional Solutes. Journal of Food Science, 47, 1259-1262.

[61]   White, A.R., Beale, A.S., Boon, R.J., Griffin, K.E., Masters, P.J. and Sutherland, R. (1985) Antibacterial Activity of Mupirocin. Bactroban, 16, 19-36.

[62]   Casewell, M.W., Hill, R.L.R. and Duckworth, G.J. (1984) The Effect of Mupirocin on the Nasal Carriage of Staphylococcus aureus. In: Mupirocin—A Novel Topical Antibiotic for the Treatment of Skin Infection, Royal Society of Medicine, International Congress and Symposium Series, London, Vol. 80, 149-154.

[63]   Leyden, J.J. (1985) Studies on the Safety of Bactroban Ointment: Potential for Contact Allergy, Contact Irritation, Phototoxicity and Photo-Allergy. Bactroban (Mupirocin) Excerpta Medica Current Clinical Practice Series, 16, 68-71.

[64]   Mellows, G. (1985) Pseudomonic Acid: Its Chemistry and Metabolism. In: Bactroban (Mupirocin) Proceedings of an International Symposium, Elsevier, Amsterdam, 3-10.

[65]   Sutherland, R., Boon, R.J., Griffin, K.E., Masters, P.J., Slocombe, B. and White, A.R. (1985) Antibacterial Activity of Mupirocin (Pseudomonic Acid), a New Antibiotic for Topical Use. Antimicrobial Agents and Chemotherapy, 27, 495-498.

[66]   Casewell, M.W. and Hill, R.L.R. (1985) In Vitro Activity of Mupirocin (“Pseudomonic Acid”) against Clinical Isolates of Staphylococcus aureus. Journal of Antimicrobial Chemotherapy, 15, 523-531.

[67]   Casewell, M.R. and Hill, R.L.R. (1986) Elimination of Nasal Carriage of Staphylococcus aureus with Mupirocin (“Pseudomonic Acid”)—A Controlled Trial. Antimicrob Chemother, 17, 36.

[68]   Ayliffe, G.A.J., Duckworth, G.J., Brumfitt, W., Casewell, M.W., Cooke, E.M., Cookson, B.D., Simmons, N.A., et al. (1986) Guidelines for the Control of Epidemic Methicillin-Resistant Staphylococcus aureus. Journal of Hospital Infection, 7, 193-201.

[69]   Hattori, M., Miyachi, K., Hada, S., Kakiuchi, N., Kikuchi, F., Tsuda, Y. and Namba, T. (1987) Effects of Long-Chain Fatty Acids and Fatty Alcohols on the Growth on Streptococcus mutans. Chemical and Pharmaceutical Bulletin, 35, 3507-3510.

[70]   Kato, N. and Shibasaki, I. (1980) The Antimicrobial Characteristics of 1-Alkanols. Journal of Antibacterial and Antifungal Agents, 8, 325-331.

[71]   Kato, N., Yanagida, S., Okahara, M. and Shibasaki, I. (1978) Antibacterial Activity of Alcohols and Oxyethylated Alcohols. Journal of Antibacterial and Antifungal Agents, 6, 527-531.

[72]   Kubo, I., Muroi, H., Himejima, H. and Kubo, A. (1993) Antibacterial Activity of Long-Chain Alcohols: The Role of Hydrophobic Alkyl Groups. Bioorganic & Medicinal Chemistry Letters, 3, 1305-1308.

[73]   Mates, A. (1974) The Effect of Alcohols on Growth and Lipase Formation by Staphylococcus aureus. Journal of Applied Bacteriology, 37, 1-6.

[74]   Togashi, N., Shiraishi, A., Nishizaka, M., Matsuoka, K., Endo, K., Hamashima, H. and Inoue, Y. (2007) Antibacterial Activity of Long-Chain Fatty Alcohols against Staphylococcus aureus. Molecules, 12, 139-148.

[75]   Menné, T. and Maibach, H.I. (1990) Exogenous Dermatoses: Environmental Dermatitis. CRC Press, Boca Raton.

[76]   Hill, R.L.R., Duckworth, G.J. and Casewell, M.W. (1988) Elimination of Nasal Carriage of Methicillin-Resistant Staphylococcus aureus with Mupirocin during a Hospital Outbreak. Journal of Antimicrobial Chemotherapy, 22, 377-384.

[77]   Bulanda, M., Gruszka, M. and Heczko, B. (1989) Effect of Mupirocin on Nasal Carriage of Staphylococcus aureus. Journal of Hospital Infection, 14, 117-124.

[78]   Reagan, D.R., Doebbeling, B.N., Pfaller, M.A., Sheetz, C.T., Houston, A.K., Hollis, R.J. and Wenzel, R.P. (1991) Elimination of Coincident Staphylococcus aureus Nasal and Hand Carriage with Intranasal Application of Mupirocin Calcium Ointment. Annals of Internal Medicine, 114, 101-106.

[79]   Redhead, R.J., Lamb, Y.J. and Rowsell, R.B. (1990) The Efficacy of Calcium Mupirocin in the Eradication of Nasal Staphylococcus aureus Carriage. The British Journal of Clinical Practice, 45, 252-254.

[80]   Doebbeling, B., Breneman, D., Marsh, R., Reagan, D. and Wenzel, R. (1992) October) Multi-Centre Study of Elimination of Staphylococcus aureus Nasal Carriage with Calcium Mupirocin Ointment in Healthy Subjects. Proceedings of the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy, Anaheim, 11-14 October 1992, 11-14.

[81]   Scully, B.E., Briones, F., Gu, J.W. and Neu, H.C. (1992) Mupirocin Treatment of Nasal Staphylococcal Colonization. Archives of Internal Medicine, 152, 353.

[82]   Doebbeling, B.N. (1994) Nasal and Hand Carriage of Staphylococcus aureus in Health Care Workers. Journal of Chemotherapy, 2, 11-17.

[83]   Fernandez, C., Gaspar, C., Torrellas, A., Vindel, A., Saez-Nieto, J.A., Cruzet, F. and Aguilar, L. (1995) A Double-Blind, Randomized, Placebo-Controlled Clinical Trial to Evaluate the Safety and Efficacy of Mupirocin Calcium Ointment for Eliminating Nasal Carriage of Staphylococcus aureus among Hospital Personnel. Journal of Antimicrobial Chemotherapy, 35, 399-408.

[84]   Van Rijen, M.M., Bonten, M., Wenzel, R.P. and Kluytmans, J.A. (2008) Intranasal Mupirocin for Reduction of Staphylococcus aureus Infections in Surgical Patients with Nasal Carriage: A Systematic Review. Journal of Antimicrobial Chemotherapy, 61, 254-261.

[85]   Kalmeijer, M.D., et al. (2002) Surgical Site Infections in Orthopedic Surgery: The Effect of Mupirocin Nasal Ointment in a Double-Blind, Randomized, Placebo-Controlled Study. Clinical Infectious Diseases, 35, 353-358.

[86]   Perl, T.M., et al. (2002) Intranasal Mupirocin to Prevent Postoperative Staphylococcus aureus Infections. New England Journal of Medicine, 346, 1871-1877.

[87]   Konvalinka, A., Errett, L. and Fong, I.W. (2006) Impact of Treating Staphylococcus aureus Nasal Carriers on Wound Infections in Cardiac Surgery. Journal of Hospital Infection, 64, 162-168.

[88]   Bode, L.G., Kluytmans, J.A., Wertheim, H.F., Bogaers, D., Vandenbroucke-Grauls, C.M., Roosendaal, R., et al. (2010) Preventing Surgical-Site Infections in Nasal Carriers of Staphylococcus aureus. The New England Journal of Medicine, 362, 9-17.



[91]   Mariana, et al. (2009) Evaluation of Modified Congo Red Agar for Detection of Biofilm Produced by Clinical Isolates of Methicillin Resistance Staphylococcus aureus. African Journal of Microbiology Research, 3, 330-338.

[92]   Arciola, C.R., et al. (2002) Detection of Slime Production by Means of an Optimised Congo Red Agar Plate Test Based on a Colourimetric Scale in Staphylococcus Epidermidis Clinical Isolates Genotyped for Ica Locus. Biomaterials, 23, 4233-4239.

[93]   Zhou, S., et al. (2013) Analysis of S. Epidermidisica A and Ica D Genes by Polymerase Chain Reaction and Slime Production: A Case Control Study. BMC Infectious Diseases, 13, 242.

[94]   Kearney, J.N., et al. (1984) The Follicular Distribution and Abundance of Resident Bacteria on Human Skin. Microbiology, 130, 797-801.

[95]   Le Fur, I., Reinberg, A., Lopez, S., Morizot, F., Mechkouri, M. and Tschachler, E. (2001) Analysis of Circadian and Ultradian Rhythms of Skin Surface Properties of Face and Forearm of Healthy Women. Journal of Investigative Dermatology, 117, 718-724.

[96]   Latreille, J., Guinot, C., Robert-Granie, C., Le Fur, I., Tenenhaus, M. and Foulley, J.L. (2004) Daily Variations in Skin Surface Properties Using Mixed Model Methodology. Skin Pharmacology and Physiology, 17, 133-140.

[97]   Vogt, A., et al. (2005) Follicular Targeting—A Promising Tool in Selective Dermatotherapy. Journal of Investigative Dermatology Symposium Proceedings, 10, 252-255.

[98]   Lademann, J., et al. (2006) Hair Follicles—A Long-Term Reservoir for Drug Delivery. Skin Pharmacology and Physiology, 19, 232-236.

[99]   Lademann, J., Richter, H., Teichmann, A., et al. (2007) Nanoparticles—An Efficient Carrier for Drug Delivery into the Hair Follicles. European Journal of Pharmaceutics and Biopharmaceutics, 66, 159-164.

[100]   Broeke-Smits, N.J.P., et al. (2010) Hair Follicles as a Niche of Staphylococcus aureus in the Nose; Is a More Effective Decolonization Strategy Needed? Journal of Hospital Infection, 76, 211-214.

[101]   Lange-Asschenfeldt, B., et al. (2011) Distribution of Bacteria in the Epidermal Layers and Hair Follicles of the Human Skin. Skin Pharmacology and Physiology, 24, 305-311.

[102]   Matard, B., et al. (2013) First Evidence of Bacterial Biofilms in the Anaerobe Part of Scalp Hair Follicles: A Pilot Comparative Study in Folliculitis Decalvans. Journal of the European Academy of Dermatology and Venereology, 27, 853-860.

[103]   Alexeyev, O.A. (2013) Bacterial Landscape of Human Skin: Seeing the Forest for the Trees. Experimental Dermatology, 22, 443-446.

[104]   Jahns, A.C., et al. (2014) Microbiology of Folliculitis: A Histological Study of 39 Cases. Apmis, 122, 25-32.

[105]   Ulmer, M., et al. (2014) New Strategies for Preoperative Skin Antisepsis. Skin Pharmacology and Physiology, 27, 283-292.

[106]   Narayan, V.A., et al. (2013) Beyond Magic Bullets: True Innovation in Health Care. Nature Reviews Drug Discovery, 12, 85-86.

[107]   Bornstein, E. (2014) Photo-Biologic Inhibition of Biofilm Formation in MRSA as a Potential Amplification of Mupirocin Nasal Carriage Eradication Therapy. Trends in Photochemistry & Photobiology, 16, 35-45.